Predicting 1-year successful clinical use of an arteriovenous access for hemodialysis using machine learning

利用机器学习预测动静脉通路在血液透析中1年临床应用的成功率

阅读:2

Abstract

Arteriovenous (AV) access is important to support long-term hemodialysis; however, a significant proportion fail due to inadequate maturation or other complications. Tools that can predict long-term AV access success may guide clinical decision-making but remain limited. We developed machine learning (ML) algorithms that predict 1-year successful clinical use of an AV access using pre-operative data. The Vascular Quality Initiative (VQI) was used to identify patients who underwent surgical AV fistula/graft creation between 2011-2024. We identified 111 pre-operative demographic, clinical, and anatomic features. Six ML models were trained with 10-fold cross-validation. Overall, 59,674 patients underwent AV access creation and 28,304 (47.4%) had 1-year successful clinical use of their index AV access. The best prediction model was XGBoost, achieving an AUROC of 0.90. In comparison, logistic regression had an AUROC of 0.70. The XGBoost model accurately predicted 1-year successful clinical use of an AV access for hemodialysis, performing better than logistic regression.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。